Merck logo

Director Global Oncology Market Access - SacTMT

Merck

Rahway, NJ; Upper Gwynedd, PAHybridPosted 1 day ago$190,800.00 - $300,300.00
Full TimeDirector & AboveCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

The Director, Oncology Global Market Access will lead global market access strategy for one or more indications of the Company's antibody drug conjugate program, Sac-TMT, working across development and commercialization to optimize patient access and long-term value. This role supports a high-priority oncology program with significant potential to improve outcomes for patients globally.

Job description

Primary Responsibilities

  • Lead global market access strategy for assigned indications, from clinical development through launch planning and commercialization.
  • Develop clear, decision-ready recommendations that connect market access, pricing, evidence, clinical development, and commercial implications.
  • Provide strategic market access input into clinical development and evidence-generation decisions, including patient population, endpoints, comparators, treatment setting, sequencing, evidence gaps, and other factors that may influence future payer value assessment and access.
  • Lead continued development and evolution of the Global Plan for Access, ensuring that key access risks, opportunities, evidence requirements, and market archetype considerations are incorporated into asset strategy.
  • Identify core value drivers and challenges to support value recognition and inform asset-level pricing strategy, informed by clinical evidence, unmet need, market readiness and competitive dynamics.
  • Lead global market access input to launch readiness and indication-expansion planning, identifying potential access barriers early and developing strategies to address them.
  • Partner with U.S., regional, and local market access organizations to incorporate critical market realities into global strategy while maintaining an enterprise and global perspective.
  • Assess payer trends, health technology assessment requirements, competitor developments, policy changes, pricing dynamics, and other external developments that could affect access or asset value.
  • Translate complex analyses and perspectives from multiple markets and functions into clear strategic choices and strong recommendations.
  • Represent Global Market Access in cross-functional teams and governance discussions, ensuring that access and pricing considerations are incorporated into key development and commercialization decisions.
  • Partner effectively across Commercial, Clinical Development, CORE, Value & Implementation, Pricing, Forecasting, Medical Affairs, Regulatory, and regional/local Market Access teams to drive integrated asset strategy.
  • Lead or coordinate market access analyses required to support key strategic decisions, including payer research, access scenario planning, forecast assumptions, launch sequencing, and risk/opportunity assessments.
  • Communicate recommendations effectively to senior leaders and governance forums through concise presentations and compelling, evidence-based storytelling.

Qualifications Required

  • BA/BS in Business, Science, Health Economics, Public Health, or a related discipline.
  • Minimum of 5 years of relevant experience in market access, pricing and reimbursement, biopharma-related management consulting, health economics/outcomes research, commercial strategy, or related areas.
  • Strong understanding of biopharma business model, product development, commercialization, pricing, reimbursement, and payer decision making.
  • Experience with, or strong familiarity with, the U.S. market combined with broader global market access exposure.
  • Demonstrated ability to translate complex quantitative and qualitative analyses into clear strategic recommendations.
  • Strong commercial orientation, analytical capability, and business acumen.
  • Excellent written and verbal communication skills, with demonstrated ability to distill complexity into a concise and compelling story for senior decision makers.
  • Experience leading complex cross-functional initiatives within a matrixed organization.
  • Strong stakeholder management, collaboration, and influencing skills.
  • Ability to exercise sound strategic judgment and drive progress in ambiguous, rapidly evolving situations.

Preferred Qualifications

  • Advanced degree such as MBA, MPH, MS, PharmD, PhD, or other relevant postgraduate qualification.
  • Significant oncology market access and/or oncology commercialization experience.
  • Experience influencing clinical development or evidence-generation strategy from a market access perspective.
  • Experience developing global pricing strategies and supporting price, access, or revenue forecasting.
  • Experience supporting oncology launches or indication expansions across multiple major markets.
  • Experience presenting recommendations to senior leadership or enterprise governance bodies.
  • Consulting experience or equivalent demonstrated strength in structured problem solving, analytics, synthesis, and executive storytelling.

Requirements

  • BA/BS in Business, Science, Health Economics, Public Health, or a related discipline
  • Minimum of 5 years of relevant experience in market access, pricing and reimbursement, biopharma-related management consulting, health economics/outcomes research, commercial strategy, or related areas
  • Strong understanding of biopharma business model, product development, commercialization, pricing, reimbursement, and payer decision making
  • Experience with, or strong familiarity with, the U.S. market combined with broader global market access exposure
  • Demonstrated ability to translate complex quantitative and qualitative analyses into clear strategic recommendations
  • Strong commercial orientation, analytical capability, and business acumen
  • Excellent written and verbal communication skills
  • Experience leading complex cross-functional initiatives within a matrixed organization
  • Strong stakeholder management, collaboration, and influencing skills
  • Ability to exercise sound strategic judgment and drive progress in ambiguous, rapidly evolving situations

Benefits

  • Medical, Dental & Vision
  • Retirement Benefits
  • 401(k)
  • Paid Holidays
  • Vacation
  • Compassionate & Sick Days
  • Annual Bonus
  • Long-Term Incentive

Company overview

Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.